27m
Stockhead on MSNDr Boreham’s Crucible: This hearing-aid stock is well tuned in to an evolving, competitive fieldCochlear is confident of its “long run” position in the hearing-aid implant game, especially in developed markets. ... Read ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results